BioCentury
ARTICLE | Clinical News

MVA EBOZ: Phase I started

May 25, 2015 7:00 AM UTC

Oxford University began a U.K. Phase I trial to evaluate intramuscular ChAd3-EBO-Z prime followed by intramuscular MVA EBOZ boost after 1 week vs. MVA EBOZ as a monotherapy in 38 volunteers. GlaxoSmi...